Syngene International Ltd Share Price (SYNGENE)
as on
| Source : NSE
Syngene International Ltd Stock Performance
as on August 20, 2025 at 4:01 PM IST
Day's Low
Day's High
₹665.85₹683.35
0.24%
Downside
2.38%
Upside
52 Week's Low
52 Week's High
₹599.55₹960.610.17%
Downside
43.92%
Upside
| Market Stats | |
| Previous Close | ₹683.05 |
| Open | ₹682.95 |
| Volume | 3.12L |
| Upper Circuit | ₹751.35 |
| Lower Circuit | ₹614.75 |
| Day's Low | ₹665.85 |
| Day's High | ₹683.35 |
| 52 Week Low | ₹599.55 |
| 52 Week High | ₹960.6 |
| Returns % | |
| 1 Month Return | + 1.79 % |
| 3 Month Return | + 8.68 % |
| 1 Year Return | -17.63 % |
| 3 Year Return | + 17.08 % |
| 5 Year Return | + 42.91 % |
Syngene International Ltd Stock Fundamentals & Key Indicators
Check Syngene International Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹27,522.78 Cr
Return on Equity (ROE)
10.6
PE Ratio (TTM)
54.08
Return on capital employed (ROCE)
13.04
Industry PE ratio
53.55
Beta (LTM)
0.81
P/B Ratio
6.3
Dividend Yield
0.17
PEG Ratio
150.23
Quarterly Earnings Growth YOY
14.53
EPS (TTM)
12.33
Sector
Healthcare
Book Value
117.44
Technical Analysis
Bearish
View Technical Analysis
Syngene International Ltd Stock's Interest Amongst Investors
Syngene International Ltd Stock Valuation
Track how Syngene International Ltd P/E has moved over time to understand its valuation trends.
Syngene International Ltd in the last 5 years
Lowest (23.09x)
March 31, 2020
Industry (53.55x)
August 19, 2025
Today (54.08x)
August 19, 2025
Highest (78.92x)
December 2, 2024
Today’s Price to Earnings Ratio: 54.08x
Syngene International Ltd Stock Recommendation
Get updated buy, sell, and hold recommendations by analysts on Syngene International Ltd.
based on 9 analysts
55.56%
Buy
11.11%
Hold
33.33%
Sell
55.56% of analysts recommend a 'BUY' rating for Syngene International Ltd. Average target price of ₹722.22
Source: S&P Global Market Intelligence
Syngene International Ltd Share Price Target
Get share price movements and forecasts by analysts on Syngene International Ltd.
Syngene International Ltd price forecast by 9 analysts
Upside of5.73%
High
₹840
Target
₹722.22
Low
₹570
Syngene International Ltd target price ₹722.22, a slight upside of 5.73% compared to current price of ₹667.45. According to 9 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Syngene International Ltd revenue growth forecast
Expected growth rate Q1, FY2027:24.82%
Forecast
Actual
Including amortisation and stock based compensations
Syngene International Ltd EPS growth forecast
EPS estimate Q1, FY2027:23.03%
Forecast
Actual
Source: S&P Global Market Intelligence
Syngene International Ltd Financial Results
Get the annual and quarterly financial summary of Syngene International Ltd, including revenue, profit, loss and more.
Syngene International Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Syngene International Ltd.
Syngene International Ltd Earnings Results
Syngene International Ltd’s net profit jumped 14.53% since last year same period to ₹86.70Cr in the Q1 2025-2026. On a quarterly growth basis, Syngene International Ltd has generated -52.7% fall in its net profits since last 3-months.
Read More about Earnings ResultsSyngene International Ltd Dividends April,2025
In the quarter ending March 2025, Syngene International Ltd has declared dividend of ₹1.25 per share on 23 Apr 2025 - translating a dividend yield of 0.37%.
Read More about Dividends
Indices Featuring Syngene International Ltd Stock
Check stock indices that include Syngene International Ltd.
Syngene International Ltd Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Syngene International Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 52.68% | ||
| Foreign Institutions | 16.5% | ||
| Mutual Funds | 20.7% | 15.88 | |
| Retail Investors | 6.45% | 7.57 | |
| Others | 3.66% |
Syngene International Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Syngene International Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,522.78 | 8.58% | 0.58 | 496 | 3,642 | |
| BUY | 11,915.72 | -7.7% | 0.52 | 413 | 2,013 | |
| BUY | 63,849.73 | 5.42% | 0.60 | 3,483 | 31,723 | |
| HOLD | 99,561.82 | 29.66% | 0.61 | 4,614 | 23,241 | |
| BUY | 70,263.13 | 19.2% | 0.00 | 1,414 | 6,445 |
Syngene International Ltd News & Key Events
Latest news and events in one place to help you make informed investing decisions in Syngene International Ltd.
Syngene International Shows Bullish Momentum - 28 Jul, 2025
Syngene International is experiencing bullish momentum with a daily RSI of 62 and MACD at 8.71. The stock is trending higher, indicating renewed buying interest, with potential upside toward ₹ 720. However, a close below ₹ 660 could signal short-term weakness, so a disciplined stop-loss is recommended.Syngene Confident in Mid-Teens Growth Outlook - 25 Jul, 2025
Syngene International's CEO highlighted strong Q1 performance and expressed confidence in achieving early-teens revenue growth for FY26, supported by robust operational momentum.Syngene Reports Strong Q1 Growth and Profit - 23 Jul, 2025
Syngene International's Q1 FY26 results show a 59% increase in net profit to ₹87 crore, with operational revenue rising 11% to ₹875 crore. The growth is attributed to successful contract conversions in research services and strong performance in the Biologics division. The company also completed a USFDA inspection with no observations, reinforcing its compliance standards.Syngene Reports Financials and Stock Surge - 15 Jul, 2025
Syngene International's quarterly financials show revenue growth but fluctuating net profits. The stock rose 2.18% with increased trading volume on July 15, 2025.Syngene Stock Shows Bullish Momentum - 04 Jul, 2025
Syngene International Ltd's stock has formed a bullish continuation pattern, indicating a potential short-term move towards ₹685. A stop loss at ₹620 is recommended to manage risk.Syngene International Announces AGM and Key Resolutions - 29 Jun, 2025
Syngene International Limited will hold its 32nd AGM on July 23, 2025, via video conferencing. Key agenda items include adopting financial statements, declaring a Rs. 1.25 dividend, and appointing new directors and auditors.
Insights on Syngene International Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, SYNGENE stock has moved up by 3.6%
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 6.00% to 6.45% in Jun 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 17.86% to 20.70% in Jun 2025 quarter
NO EFFECTAgainst Peers
In the last 1 year, Vimta Labs Ltd has given 166.4% return, outperforming this stock by 184.1%
- NO EFFECT
Against Peers
In the last 3 years, Vimta Labs Ltd has given 246.7% return, outperforming this stock by 229.7%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 19.47% to 16.50% in Jun 2025 quarter
- NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, 183.3 Cr → 86.7 Cr (in ₹), with an average decrease of 52.7% per quarter
- NEGATIVE IMPACT
Promoter Holding Down
Promoters have decreased holdings from 52.74% to 52.68% in Jun 2025 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 1.03K Cr → 892.2 Cr (in ₹), with an average decrease of 14.0% per quarter
About Syngene International Ltd
Revenue: ₹874.50Cr as on June 2025 (Q1 FY26)
Net Profit: ₹86.70Cr as on June 2025 (Q1 FY26)
Listing date: 11 Aug, 2015
Chairperson Name: Kiran Mazumdar Shaw
| Organisation | Syngene International Ltd |
| Industry | Healthcare |
| CEO | Kiran Mazumdar Shaw |
| E-voting on shares | Click here to vote |
Mutual Funds that own Syngene International Ltd Stock
Check out the Mutual Funds with significant holdings in Syngene International Ltd.
FAQs
What is Syngene International Ltd share price today?
Syngene International Ltd share price today stands at ₹667.45, Open: ₹682.95, Previous Close: ₹683.05, High: ₹683.35, Low: ₹665.85, 52 Week High: ₹960.6, 52 Week Low: ₹599.55 as on .
How to buy Syngene International Ltd shares ?
To buy Syngene International Ltd shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for SYNGENE or Syngene International Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Syngene International Ltd shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Syngene International Ltd?
Today's traded volume of Syngene International Ltd is 3.12L. Which means that 3.12L shares of Syngene International Ltd were bought and sold on the stock market during today's trading session.
What is Syngene International Ltd's market cap today?
Today's market capitalisation of Syngene International Ltd is ₹27,522.78 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Syngene International Ltd?
Syngene International Ltd’s 52 week high is ₹960.6 and 52 week low is ₹599.55. The current share price of Syngene International Ltd is ₹667.45, which is -30.52% down from its 52 week high and 11.33% up from its 52 week low.